Skip to Main Content

Etoposide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Licensed for intrathecal use

Products licensed for intrathecal use are the first line option and should be used wherever suitable.

There are currently no known etoposide products licensed for intrathecal administration.

Not licensed for intrathecal use, limited information available

Products with partial information that are not licensed for intrathecal administration can still sometimes be used. Refer to the advice in our article and complete a risk assessment to enable you to interpret the details below and choose an appropriate product.

Accord

Strength

20mg/mL in 5mL vial
20mg/mL in 10mL vial
20mg/mL in 12.5mL vial
20mg/mL in 20mL vial
20mg/ml in 25mL vial
20mg/mL in 50mL vial

Excipients

Citric acid, anhydrous, benzyl alcohol (30 mg/ml), polysorbate 80, macrogol 300, ethanol, anhydrous (240.64 mg/ml)

Osmolarity / osmolality

No information

pH

3.0 – 4.0

Endotoxin content

≤ 1.3 EU/mg

Hikma

Strength

20mg/mL in 5mL ampoule
20mg/mL in 10mL ampoule
20mg/mL in 20mL ampoule
20mg/ml in 25mL ampoule
20mg/mL in 50mL ampoule

Excipients

Citric acid anhydrous, benzyl alcohol, polysorbate 80, polyethyleneglycol , ethanol 96%

Osmolarity / osmolality

338 – 404 mOsm/kg

pH

3.1 – 4.0

Endotoxin content

≤ 5 IU/mL

Fresenius

Strength

20mg/mL in 5mL vial
20mg/mL in 10mL vial
20mg/mL in 25mL vial
20mg/mL in 50mL vial

Excipients

Macrogol 300, polysorbate 80, benzyl alcohol (30mg/mL), ethanol (241.4 mg/mL), citric acid (anhydrous)

Osmolarity / osmolality

No information

pH

3 – 4

Endotoxin content

≤ 2.0 EU/mg

Neon (Etopophos®)

Strength

100mg vial

Excipients

Dextran 40, Sodium citrate

Osmolarity / osmolality

No information

pH

No information

Endotoxin content

No information

Update history

  1. Republished
  2. Full monograph update
  1. Title and URL shortened.
  1. Published